Published in Hepatitis Weekly, June 20th, 2005
The results were presented at ATS 2005, the annual International Conference of the American Thoracic Society (ATS), in San Diego, California. Other data presented at ATS 2005 included an independent investigator-initiated meta analysis that evaluated the effect of Actimmune treatment in prolonging survival in patients with IPF, results of the use of the Composite Pulmonary Index (CPI) in predicting mortality in IPF patients, and preclinical findings on the mechanism of action of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.